Using our Arestat™ technology platform, we are developing enhanced medicines for diabetes and other indications through our proprietary pipeline and in partnership with leading pharmaceutical and biotechnology companies

Our Products

Our potential products for diabetes and for specialist hospital use are designed to improve patient outcomes and enable healthier lives

Our Partners

We work with many of the top 20 leading pharmaceutical companies to enhance product formats, find solutions to development challenges and create differentiated products offering the potential for significant improvements in patient safety and convenience

Latest News and Events

  • 11th November 2021

    ARECOR GRANTED KEY CANADIAN PATENT FOR PROPRIETARY TECHNOLOGY ENABLING HIGHLY CONCENTRATED BIOTHERAPEUTICS

  • 1st November 2021

    ARECOR ANNOUNCES EXCLUSIVE COLLABORATION WITH LEADING GLOBAL MEDICAL PRODUCTS COMPANY

  • 22nd October 2021

    Arecor commentary in MedNous on how faster insulin can enable the artificial pancreas